Concord Medical Services
4 hedge funds and large institutions have $608K invested in Concord Medical Services in 2020 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% less ownership
Funds ownership: 0.04% → 0.04% (-0%)
9% less capital invested
Capital invested by funds: $666K → $608K (-$58K)
20% less funds holding
Funds holding: 5 → 4 (-1)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$974 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$6K |
| 2 |
SPL
Smart Portfolios LLC
Seattle,
Washington
|
-$3.25K |
| 3 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$260 |
CCM Hedge Fund Activity: Q2 2020 in Review
4 of the 4,887 institutional investors tracked by Wall St. Rank reported a position in Concord Medical Services (CCM) for Q2 2020, worth a combined $608K — down 8.7% from $666K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CCM and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, adding an estimated $974. The largest seller was UBS Group, exiting entirely with an estimated $6K sold.
- 4 institutional investors held Concord Medical Services (CCM) as of Q2 2020, down from 5 in Q1 2020.
- Funds reported $608K of Concord Medical Services stock for Q2 2020, down 8.7% quarter-over-quarter.
- 0 funds opened new Concord Medical Services positions in Q2 2020 and 1 closed out, a net change of -1 holder.
- The largest Concord Medical Services buyer in Q2 2020 was Renaissance Technologies, an estimated $974 added.
- The largest Concord Medical Services seller in Q2 2020 was UBS Group, an estimated $6K sold.
Based on aggregated 13F filings for Q2 2020.